HBV vaccine (Mega-CD40L adjuvanted) (Multimeric Biotherapeutics)

N/A

Report date: 2025/01/26 19:07:56

Base Information

Drug NameHBV vaccine (Mega-CD40L adjuvanted) (Multimeric Biotherapeutics)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMultimeric Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMultimeric Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A